Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)

Frey, Reiner; Mück, Wolfgang; Kirschbaum, Nina; Krätzschmar, Jörn; Weimann, Gerrit; Wensing, Georg

doi:10.1186/1471-2210-9-S1-P15

BMC Pharmacology

Article metrics
Last updated: Fri, 19 Apr 2024 15:35:41 Z

Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)

Access & Citations

4009

Article Accesses
0

Web of Science
2

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.